Physician profile
Leo B Meier
NPI 1669488623
$1,487.81
in general payments reported to CMS, 2019-2025
18 companies · $341 in 2025
The $341 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $547 · 2022: $170 · 2023: $293 · 2024: $138 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $771.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $338.64 | 2021-2025 | Farxiga, Breztri |
| Novo Nordisk INC | $293.02 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $188.96 | 2021-2025 | Mounjaro, Jardiance, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.08 | 2021-2025 | Jardiance, Tradjenta |
| Amgen INC. | $129.72 | 2021-2025 | Repatha, Otezla, Otezla |
| Sumitomo Pharma America, INC. | $45.47 | 2024-2025 | Gemtesa |
| Abbvie INC. | $43.99 | 2021-2023 | |
| Glaxosmithkline, LLC. | $42.15 | 2021-2023 | Trelegy Ellipta |
| E.R. Squibb & Sons, L.L.C. | $41.32 | 2021-2023 | Eliquis |
| Pfizer INC. | $40.83 | 2021 | |
| Amarin Pharma, INC. | $33.04 | 2021 | |
| Exact Sciences Corporation | $25.10 | 2025 | Cologuard Collection Kit |
| Currax Pharmaceuticals LLC | $23.88 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $21.00 | 2021 | |
| Eisai INC. | $18.43 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $15.06 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.33 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leo Meier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.